Since the first original work in 1989 showing that Mac-2 antigen, actually known as Gal-3, binds to IgE from basophilic leukemia cells, a large number of subsequent studies report that Gal-3 functions in other types of tumors (recently reviewed in [54,55]). The gene discussed is LGALS3; the disease is leukemia.